ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.00%
US Dollar vs MXN
17.7329
0.01%
Brent Oil
82.975
-1.62%
Bitcoin
63,968.98
-1.37%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Co Diagnostics Inc (CODX)

  7. Co Diagnostics Inc (CODX) Noticias

CODX

Co Diagnostics (CODX)

Co Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CODX
FechaHoraFuenteTítuloSímboloCompañía
03/08/202005:30PR Newswire (US)Co-Diagnostics, Inc. Technology to be Used in FDA-Authorized Self-Collected COVID-19 Saliva TestNASDAQ:CODXCo Diagnostics Inc
31/07/202010:23PR Newswire (US)Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva TestNASDAQ:CODXCo Diagnostics Inc
23/07/202007:45InvestorWireGovernments Around the World Escalate Precautions Amid the SurgeNASDAQ:CODXCo Diagnostics Inc
14/07/202006:30GlobeNewswire Inc.H.C. Wainwright reiterates ‘Buy’ for Co-Diagnostics (NASDAQ:CODX) with a $35 Price Target as COVID-19 Surge Boosts Testin...NASDAQ:CODXCo Diagnostics Inc
18/06/202010:16PR Newswire (US)Securities Class Action Lawsuit Filed Against COVID-19 test maker, Co-Diagnostics, Inc. by Marcus Neiman Rashbaum & Pineiro, ...NASDAQ:CODXCo Diagnostics Inc
09/06/202006:30PR Newswire (US)Co-Diagnostics, Inc. to Join Russell 2000® and Russell 3000® IndexesNASDAQ:CODXCo Diagnostics Inc
08/06/202014:16Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CODXCo Diagnostics Inc
05/06/202016:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CODXCo Diagnostics Inc
04/06/202013:42Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:CODXCo Diagnostics Inc
04/06/202013:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CODXCo Diagnostics Inc
28/05/202008:00GlobeNewswire Inc.Co-Diagnostics (NASDAQ:CODX) Analysts Set Price Target Between $30 and $36NASDAQ:CODXCo Diagnostics Inc
27/05/202005:30PR Newswire (US)Co-Diagnostics, Inc. to Present at COVID-19 Virtual Conference Hosted by Maxim Group on May 27, 2020NASDAQ:CODXCo Diagnostics Inc
26/05/202005:30PR Newswire (US)Co-Diagnostics, Inc. COVID-19 Test Successfully Used to Identify Coronavirus in Cancer TissueNASDAQ:CODXCo Diagnostics Inc
15/05/202008:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CODXCo Diagnostics Inc
14/05/202017:01PR Newswire (US)Co-Diagnostics, Inc. Releases Prepared Remarks for First Quarter 2020 Conference CallNASDAQ:CODXCo Diagnostics Inc
14/05/202015:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CODXCo Diagnostics Inc
14/05/202015:01PR Newswire (US)Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter UpdateNASDAQ:CODXCo Diagnostics Inc
12/05/202015:40PR Newswire (US)Co-Diagnostics, Inc. Announces Q1 2020 Earnings Release Date and Earnings CallNASDAQ:CODXCo Diagnostics Inc
04/05/202005:30PR Newswire (US)Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test KitsNASDAQ:CODXCo Diagnostics Inc
20/04/202005:30PR Newswire (US)Co-Diagnostics, Inc. Announces Expansion of COVID-19 Test Orders in the United StatesNASDAQ:CODXCo Diagnostics Inc
16/04/202005:30PR Newswire (US)Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva SamplesNASDAQ:CODXCo Diagnostics Inc
15/04/202010:47Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CODXCo Diagnostics Inc
14/04/202005:30PR Newswire (US)Co-Diagnostics, Inc. Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer BaseNASDAQ:CODXCo Diagnostics Inc
06/04/202005:30PR Newswire (US)Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 TestNASDAQ:CODXCo Diagnostics Inc
31/03/202009:02Business WireCo-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress UpdatesNASDAQ:CODXCo Diagnostics Inc
30/03/202016:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CODXCo Diagnostics Inc
25/03/202010:30GlobeNewswire Inc.Co-Diagnostics (NASDAQ:CODX) Reiterated Buy; Joins Distinguished Group Racing to Meet Unprecedented Global Demand for COVID-1...NASDAQ:CODXCo Diagnostics Inc
20/03/202007:00GlobeNewswire Inc.PreCheck Begins Filling Orders for Coronavirus (COVID-19) PCR Test and Announces Distribution Agreements in Romania and Moldo...NASDAQ:CODXCo Diagnostics Inc
20/03/202005:30Business WireCo-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use AuthorizationNASDAQ:CODXCo Diagnostics Inc
19/03/202005:30Business WireCo-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 DiagnosticNASDAQ:CODXCo Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:CODX

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
BAC
Bank of America
NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
FX
EURMXN
Euro vs MXN
COIN
BTCUSD
Bitcoin
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados